$Evoke Pharma(EVOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-007260 Size: 5 KB 网页链接
$Evoke Pharma(EVOK)$ 8-K Current report, item 1.01 Accession Number: 0001564590-22-003614 Act: 34 Size: 163 KB 网页链接
$Evoke Pharma(EVOK)$ 8-K Current report, item 8.01 Accession Number: 0001564590-22-000279 Act: 34 Size: 161 KB 网页链接
$Evoke Pharma(EVOK)$ 8-K Current report, item 3.01 Accession Number: 0001193125-21-370575 Act: 34 Size: 147 KB 网页链接
$Evoke Pharma(EVOK)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-21-056208 Act: 34 Size: 4 MB 网页链接
$Evoke Pharma(EVOK)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-21-056189 Act: 34 Size: 555 KB 网页链接
$Evoke Pharma(EVOK)$ 8-K Current report, item 8.01 Accession Number: 0001564590-21-051181 Act: 34 Size: 169 KB 网页链接
$Evoke Pharma(EVOK)$ 8-K Current report, item 8.01 Accession Number: 0001564590-21-049429 Act: 34 Size: 170 KB 网页链接
$Evoke Pharma(EVOK)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-21-043994 Act: 34 Size: 3 MB 网页链接
$Evoke Pharma(EVOK)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-21-043948 Act: 34 Size: 414 KB 网页链接